Improvement of Radioimmunotherapy Using Pretargeting

During the past two decades, considerable research has been devoted to radionuclide therapy using radiolabeled monoclonal antibodies and receptor binding agents. Conventional radioimmunotherapy (RIT) is now an established and important tool in the treatment of hematologic malignancies such as Non-Ho...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Frampas, Eric, Rousseau, Caroline, Bodet-Milin, Caroline, Barbet, Jacques, Chatal, Jean-Francois, Kraeber-Bodéré, Françoise
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2013
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687199/
https://ncbi.nlm.nih.gov/pubmed/23802097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00159
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi